A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular Carcinoma
Clinical trial NCT03663114 · COMPLETED
Trial details
- NCT number
- NCT03663114
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-07-02
- Primary completion
- 2020-02-20
- Enrollment
- 713
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.